Synopsis of recent research by authors named "Shaik Haseena"
- Shaik Haseena's research primarily focuses on the development of innovative drug delivery systems, particularly liposomal formulations, showcasing their selective cytotoxicity towards cancer cells while sparing healthy cells.
- The author has explored combinational cancer therapies, as seen in the simultaneous delivery of doxorubicin and curcumin encapsulated in liposomes targeting tumor vasculature, highlighting the potential of curcumin to enhance treatment efficacy.
- Additionally, Haseena has synthesized novel materials such as phenylene ethynylene polymers and tetrathiafulvalene-based molecular tweezers, emphasizing their applications in facilitating the dispersion of carbon nanotubes and as receptors for fullerenes, respectively.
